1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global AI Drug Development Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Drug Design
  • 1.3.3 Drug Synthesis
  • 1.3.4 Other
• 1.4 Market by Application
  • 1.4.1 Global AI Drug Development Market Share by Application: 2020 VS 2026
  • 1.4.2 Tumor
  • 1.4.3 Nervous System
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global AI Drug Development Market Perspective (2015-2026)
• 2.2 AI Drug Development Growth Trends by Regions
  • 2.2.1 AI Drug Development Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 AI Drug Development Historic Market Share by Regions (2015-2020)
  • 2.2.3 AI Drug Development Forecasted Market Size by Regions (2021-2026)
• 2.3 AI Drug Development Industry Dynamic
  • 2.3.1 AI Drug Development Market Trends
  • 2.3.2 AI Drug Development Market Drivers
  • 2.3.3 AI Drug Development Market Challenges
  • 2.3.4 AI Drug Development Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top AI Drug Development Players by Market Size
  • 3.1.1 Global Top AI Drug Development Players by Revenue (2015-2020)
  • 3.1.2 Global AI Drug Development Revenue Market Share by Players (2015-2020)
• 3.2 Global AI Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by AI Drug Development Revenue
• 3.4 Global AI Drug Development Market Concentration Ratio
  • 3.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2019
• 3.5 Key Players AI Drug Development Area Served
• 3.6 Key Players AI Drug Development Product Solution and Service
• 3.7 Date of Enter into AI Drug Development Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 AI Drug Development Breakdown Data by Type

• 4.1 Global AI Drug Development Historic Market Size by Type (2015-2020)
• 4.2 Global AI Drug Development Forecasted Market Size by Type (2021-2026)

5 AI Drug Development Breakdown Data by Application

• 5.1 Global AI Drug Development Historic Market Size by Application (2015-2020)
• 5.2 Global AI Drug Development Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America AI Drug Development Market Size (2015-2026)
• 6.2 North America AI Drug Development Market Size by Type (2015-2020)
• 6.3 North America AI Drug Development Market Size by Application (2015-2020)
• 6.4 North America AI Drug Development Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe AI Drug Development Market Size (2015-2026)
• 7.2 Europe AI Drug Development Market Size by Type (2015-2020)
• 7.3 Europe AI Drug Development Market Size by Application (2015-2020)
• 7.4 Europe AI Drug Development Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific AI Drug Development Market Size (2015-2026)
• 8.2 Asia-Pacific AI Drug Development Market Size by Type (2015-2020)
• 8.3 Asia-Pacific AI Drug Development Market Size by Application (2015-2020)
• 8.4 Asia-Pacific AI Drug Development Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America AI Drug Development Market Size (2015-2026)
• 9.2 Latin America AI Drug Development Market Size by Type (2015-2020)
• 9.3 Latin America AI Drug Development Market Size by Application (2015-2020)
• 9.4 Latin America AI Drug Development Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa AI Drug Development Market Size (2015-2026)
• 10.2 Middle East & Africa AI Drug Development Market Size by Type (2015-2020)
• 10.3 Middle East & Africa AI Drug Development Market Size by Application (2015-2020)
• 10.4 Middle East & Africa AI Drug Development Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Insilico Medicine
  • 11.1.1 Insilico Medicine Company Details
  • 11.1.2 Insilico Medicine Business Overview
  • 11.1.3 Insilico Medicine AI Drug Development Introduction
  • 11.1.4 Insilico Medicine Revenue in AI Drug Development Business (2015-2020))
  • 11.1.5 Insilico Medicine Recent Development
• 11.2 Cyclica
  • 11.2.1 Cyclica Company Details
  • 11.2.2 Cyclica Business Overview
  • 11.2.3 Cyclica AI Drug Development Introduction
  • 11.2.4 Cyclica Revenue in AI Drug Development Business (2015-2020)
  • 11.2.5 Cyclica Recent Development
• 11.3 XtalPi Inc.
  • 11.3.1 XtalPi Inc. Company Details
  • 11.3.2 XtalPi Inc. Business Overview
  • 11.3.3 XtalPi Inc. AI Drug Development Introduction
  • 11.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2015-2020)
  • 11.3.5 XtalPi Inc. Recent Development
• 11.4 Exscientia Limited
  • 11.4.1 Exscientia Limited Company Details
  • 11.4.2 Exscientia Limited Business Overview
  • 11.4.3 Exscientia Limited AI Drug Development Introduction
  • 11.4.4 Exscientia Limited Revenue in AI Drug Development Business (2015-2020)
  • 11.4.5 Exscientia Limited Recent Development
• 11.5 AiCure, LLC
  • 11.5.1 AiCure, LLC Company Details
  • 11.5.2 AiCure, LLC Business Overview
  • 11.5.3 AiCure, LLC AI Drug Development Introduction
  • 11.5.4 AiCure, LLC Revenue in AI Drug Development Business (2015-2020)
  • 11.5.5 AiCure, LLC Recent Development
• 11.6 Atomwise
  • 11.6.1 Atomwise Company Details
  • 11.6.2 Atomwise Business Overview
  • 11.6.3 Atomwise AI Drug Development Introduction
  • 11.6.4 Atomwise Revenue in AI Drug Development Business (2015-2020)
  • 11.6.5 Atomwise Recent Development
• 11.7 Biovista Inc.
  • 11.7.1 Biovista Inc. Company Details
  • 11.7.2 Biovista Inc. Business Overview
  • 11.7.3 Biovista Inc. AI Drug Development Introduction
  • 11.7.4 Biovista Inc. Revenue in AI Drug Development Business (2015-2020)
  • 11.7.5 Biovista Inc. Recent Development
• 11.8 Breg，Inc.
  • 11.8.1 Breg，Inc. Company Details
  • 11.8.2 Breg，Inc. Business Overview
  • 11.8.3 Breg，Inc. AI Drug Development Introduction
  • 11.8.4 Breg，Inc. Revenue in AI Drug Development Business (2015-2020)
  • 11.8.5 Breg，Inc. Recent Development
• 11.9 Numerate
  • 11.9.1 Numerate Company Details
  • 11.9.2 Numerate Business Overview
  • 11.9.3 Numerate AI Drug Development Introduction
  • 11.9.4 Numerate Revenue in AI Drug Development Business (2015-2020)
  • 11.9.5 Numerate Recent Development
• 11.10 Cloud Pharmaceuticals
  • 11.10.1 Cloud Pharmaceuticals Company Details
  • 11.10.2 Cloud Pharmaceuticals Business Overview
  • 11.10.3 Cloud Pharmaceuticals AI Drug Development Introduction
  • 11.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2015-2020)
  • 11.10.5 Cloud Pharmaceuticals Recent Development
• 11.11 IBM
  • 10.11.1 IBM Company Details
  • 10.11.2 IBM Business Overview
  • 10.11.3 IBM AI Drug Development Introduction
  • 10.11.4 IBM Revenue in AI Drug Development Business (2015-2020)
  • 10.11.5 IBM Recent Development
• 11.12 NuMedii
  • 10.12.1 NuMedii Company Details
  • 10.12.2 NuMedii Business Overview
  • 10.12.3 NuMedii AI Drug Development Introduction
  • 10.12.4 NuMedii Revenue in AI Drug Development Business (2015-2020)
  • 10.12.5 NuMedii Recent Development
• 11.13 BenevolentAI
  • 10.13.1 BenevolentAI Company Details
  • 10.13.2 BenevolentAI Business Overview
  • 10.13.3 BenevolentAI AI Drug Development Introduction
  • 10.13.4 BenevolentAI Revenue in AI Drug Development Business (2015-2020)
  • 10.13.5 BenevolentAI Recent Development
• 11.14 Lam Therapeutics
  • 10.14.1 Lam Therapeutics Company Details
  • 10.14.2 Lam Therapeutics Business Overview
  • 10.14.3 Lam Therapeutics AI Drug Development Introduction
  • 10.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2015-2020)
  • 10.14.5 Lam Therapeutics Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

AI Drug Development market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global AI Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Drug Design
Drug Synthesis
Other

Market segment by Application, split into
Tumor
Nervous System
Other

Based on regional and country-level analysis, the AI Drug Development market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE

In the competitive analysis section of the report, leading as well as prominent players of the global AI Drug Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Insilico Medicine
Cyclica
XtalPi Inc.
Exscientia Limited
AiCure, LLC
Atomwise
Biovista Inc.
Breg，Inc.
Numerate
Cloud Pharmaceuticals
IBM
NuMedii
BenevolentAI